Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 270

1.

Digitalis: a dangerous drug in atrial fibrillation?

Testa L, Bhindi R, Banning AP.

Heart. 2008 Dec;94(12):1654; author reply 1654-5. No abstract available.

PMID:
19011140
2.

Digitalis: a dangerous drug in atrial fibrillation? An analysis of the SPORTIF III and V data.

Gjesdal K, Feyzi J, Olsson SB.

Heart. 2008 Feb;94(2):191-6. Epub 2007 May 4.

PMID:
17483128
3.

The risks of warfarin use in the elderly.

Bereznicki LR, Peterson GM, Jackson SL, Jeffrey EC.

Expert Opin Drug Saf. 2006 May;5(3):417-31. Review.

PMID:
16610970
4.

Ximelagatran data fail to impress FDA.

Thompson CA.

Am J Health Syst Pharm. 2004 Dec 1;61(23):2472, 2474-5, 2480. No abstract available.

PMID:
15595219
5.

Ximelagatran: light at the end of the tunnel or the next tunnel?

Sander GE, Giles TD.

Am J Geriatr Cardiol. 2004 Jul-Aug;13(4):221-4. Review. No abstract available.

PMID:
15269571
6.

[Story of a predictable death: the end of vitamin K antagonists?].

Lloret Linares C, Bergmann JF.

Rev Med Interne. 2010 Feb;31(2):88-90. doi: 10.1016/j.revmed.2009.09.030. Epub 2009 Nov 17. French. No abstract available.

PMID:
19926365
8.

Transient reversion of atrial fibrillation during an episode of digitalis toxicity.

Guijarro-Morales A, Maldonado-Martín A, Guijarro-Huertas GM, Marti-García JL.

Int J Cardiol. 2002 Apr;83(1):87-9. No abstract available.

PMID:
11959390
9.

Ximelagatran: an eulogy.

Boos CJ, Lip GY.

Thromb Res. 2006;118(3):301-4. Epub 2006 Apr 19. No abstract available.

PMID:
16626788
10.

[Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].

Tandoğan I.

Anadolu Kardiyol Derg. 2007 Jun;7(2):216; author reply 218-9. Turkish. No abstract available.

11.

[Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].

Kiraç FS.

Anadolu Kardiyol Derg. 2007 Jun;7(2):214-5; author reply 218-9. Turkish. No abstract available.

12.

[Anticoagulants in non-valvular atrial fibrillation. A clinical dilemma in practice].

Carlsäter J, Kristjansson G, Nilsson G.

Lakartidningen. 1994 Aug 31;91(35):3053-6. Swedish. No abstract available.

PMID:
7983939
13.

Current challenges of anticoagulant treatment.

Ginghină C, Giuşcă S, Serban M, Popescu BA, Jurcuţ R, Uscăţescu V.

Rom J Intern Med. 2007;45(3):221-7.

PMID:
18333353
16.

Atrial fibrillation and the urologist.

Ghani KR, Anson KM, Camm AJ.

BJU Int. 2004 Aug;94(3):254-5. No abstract available.

17.

Clopidogrel plus aspirin in atrial fibrillation.

Goldstein LB.

N Engl J Med. 2009 Sep 24;361(13):1313; author reply 1314-5. No abstract available.

PMID:
19780217
18.

How can 'Hy's law' help the clinician?

Senior JR.

Pharmacoepidemiol Drug Saf. 2006 Apr;15(4):235-9. No abstract available.

PMID:
16552792
19.

Clopidogrel plus aspirin in atrial fibrillation.

Richard T, Butaffuoco F, Vanhaeverbeek M.

N Engl J Med. 2009 Sep 24;361(13):1313; author reply 1314-5. No abstract available.

PMID:
19780216
20.

Predicting bleeding risk in anticoagulated patients with atrial fibrillation.

Rosenstein R, DiMaggio E.

J Am Coll Cardiol. 2011 Sep 20;58(13):1399; author reply 1398-9. doi: 10.1016/j.jacc.2011.02.077. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk